​Costa Panagos

Costa PanagosCosta Panagos is president, clinical operations, responsible for the global delivery and customer experience of all IQVIA’s clinical development services, including our IQVIA CORE-enabled trials and virtual trials. He is also responsible for increasing the use of advances such as CRA technology and flexible staffing models to improve operational efficiencies.  

Costa was recently chief executive officer of Q2 Solutions, the joint venture between IQVIA and Quest Laboratories.  Under his leadership, Q2 Solutions became a leading global clinical trials laboratory services organization which includes Central Laboratory, Genomics, and BioAnalytical and ADME operations.  During his more than 19-year career at IQVIA, Costa has held several senior clinical and commercial leadership roles, including senior vice president and global head of IQVIA’s Global Laboratories as well as leading its Global Sales Operations organization. Prior to IQVIA, Costa held various roles in the pharmaceutical division of Bayer.

Costa earned a bachelor's degree in biology from Brown University and an MBA from the Booth School of Business, University of Chicago.